Ako Ishihara

1.3k total citations
14 papers, 1.0k citations indexed

About

Ako Ishihara is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ako Ishihara has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ako Ishihara's work include Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell Adhesion Molecules Research (4 papers). Ako Ishihara is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell Adhesion Molecules Research (4 papers). Ako Ishihara collaborates with scholars based in United States, Japan and United Kingdom. Ako Ishihara's co-authors include Jun Ishihara, Jeffrey A. Hubbell, Kazuto Fukunaga, Aslan Mansurov, Peyman Hosseinchi, Melody A. Swartz, Koichi Sasaki, Lambert Potin, John‐Michael Williford and Michael White and has published in prestigious journals such as Nature Communications, Blood and Science Advances.

In The Last Decade

Ako Ishihara

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ako Ishihara United States	10	412	385	295	231	181	14	1.0k
Kazuto Fukunaga Japan	10	214 0.5×	220 0.6×	243 0.8×	187 0.8×	226 1.2×	10	783
Ji Min Oh South Korea	21	399 1.0×	255 0.7×	1.4k 4.9×	360 1.6×	147 0.8×	50	2.1k
Vincent Sarrazy France	14	177 0.4×	219 0.6×	359 1.2×	152 0.7×	62 0.3×	19	1.2k
Michael K. Lichtman United States	6	484 1.2×	390 1.0×	267 0.9×	65 0.3×	70 0.4×	10	1.1k
Aslan Mansurov United States	13	384 0.9×	351 0.9×	248 0.8×	200 0.9×	85 0.5×	18	808
Se Hwan Baek South Korea	15	332 0.8×	188 0.5×	1.1k 3.7×	294 1.3×	99 0.5×	19	1.5k
Liya Zhu South Korea	16	349 0.8×	205 0.5×	1.1k 3.8×	298 1.3×	100 0.6×	26	1.5k
Henrik J. Jürgensen Denmark	18	343 0.8×	290 0.8×	322 1.1×	52 0.2×	70 0.4×	25	1.1k
Cinzia Zucchini Italy	19	225 0.5×	178 0.5×	416 1.4×	141 0.6×	134 0.7×	51	1.2k
Christina Philippeos United Kingdom	11	262 0.6×	238 0.6×	289 1.0×	121 0.5×	61 0.3×	17	970

Countries citing papers authored by Ako Ishihara

Since Specialization

Citations

This map shows the geographic impact of Ako Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ako Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ako Ishihara more than expected).

Fields of papers citing papers by Ako Ishihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ako Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ako Ishihara. The network helps show where Ako Ishihara may publish in the future.

Co-authorship network of co-authors of Ako Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Ako Ishihara. A scholar is included among the top collaborators of Ako Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ako Ishihara. Ako Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Budina, Erica, Shijie Cao, Elyse A. Watkins, et al.. (2025). Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitis. Cell Reports Medicine. 6(7). 102231–102231.

Alpar, Aaron T., Ako Ishihara, Aslan Mansurov, et al.. (2023). Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds. npj Regenerative Medicine. 8(1). 49–49. 6 indexed citations

Ishihara, Ako, Jun Ishihara, Elyse A. Watkins, et al.. (2020). Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature Biomedical Engineering. 5(5). 387–398. 31 indexed citations

Mansurov, Aslan, Jun Ishihara, Peyman Hosseinchi, et al.. (2020). Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nature Biomedical Engineering. 4(5). 531–543. 178 indexed citations

Ishihara, Ako, Jun Ishihara, Elyse A. Watkins, et al.. (2020). Publisher Correction: Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature Biomedical Engineering. 4(11). 1117–1117. 2 indexed citations

Yuba, Eiji, Erica Budina, Kiyomitsu Katsumata, et al.. (2020). Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin‐10 in Murine Models. Arthritis & Rheumatology. 73(5). 769–778. 26 indexed citations

Ishihara, Jun, Ako Ishihara, Koichi Sasaki, et al.. (2019). Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Science Translational Medicine. 11(487). 147 indexed citations

Ishihara, Jun, Ako Ishihara, Richard Starke, et al.. (2019). The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood. 133(24). 2559–2569. 88 indexed citations

Williford, John‐Michael, Jun Ishihara, Ako Ishihara, et al.. (2019). Recruitment of CD103 ⁺ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Science Advances. 5(12). eaay1357–eaay1357. 99 indexed citations

10.

Sasaki, Koichi, Jun Ishihara, Ako Ishihara, et al.. (2019). Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy. Science Advances. 5(8). eaaw6081–eaaw6081. 69 indexed citations

11.

Katsumata, Kiyomitsu, Jun Ishihara, Kazuto Fukunaga, et al.. (2019). Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-α antibody in a murine model of rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 298–298. 9 indexed citations

12.

Katsumata, Kiyomitsu, Jun Ishihara, Aslan Mansurov, et al.. (2019). Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Science Advances. 5(11). eaay1971–eaay1971. 46 indexed citations

13.

Ishihara, Jun, Ako Ishihara, Kazuto Fukunaga, et al.. (2018). Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing. Nature Communications. 9(1). 2163–2163. 186 indexed citations

14.

Ishihara, Jun, Kazuto Fukunaga, Ako Ishihara, et al.. (2017). Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events. Science Translational Medicine. 9(415). 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact